# Combined Dry Powder Tobramycin and Nebulized Colistin Inhalation in CF Patients

> **NCT03341741** · PHASE3 · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 26 (actual)

## Conditions studied

- Cystic Fibrosis With Pulmonary Manifestations

## Interventions

- **DRUG:** Tobramycin Powder
- **DRUG:** Colistin

## Key facts

- **NCT ID:** NCT03341741
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-11
- **Primary completion:** 2015-12-19
- **Final completion:** 2016-11-25
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2017-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03341741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03341741, "Combined Dry Powder Tobramycin and Nebulized Colistin Inhalation in CF Patients". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT03341741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*